FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida BPC 157 Banned: Key Facts on the Latest FDA Decision The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Rapid 250mcg Pure Prescriptions Compounded "semaglutide" is not FDA approved semaglutide.com